US Department of Health and Human Services
Latest From US Department of Health and Human Services
Medtronic is leading the race to get an artificial pancreas to market, and by this time next year the company could be the first manufacturer to reach the finish line. The achievement would be historic, but with a group of established and young companies running about two to three years behind, Medtronic will have to continue to improve on its offerings to maintain its impressive dominance.
The role digital health will ultimately play in the overall health care market is still evolving, but it is becoming clearer that consumers and consumer-based products will play a role. The merging of consumer and medical was evident at CES in Las Vegas, where an increasing number of businesses are showcasing new products for the digital health market, which is expected to reach $233 billion by 2020.
DJO Global Inc. launched its new EMPOWR 3D Knee in November amid the growing trend toward outpatient total joint replacement in younger and more active patients. Advanced implant sizing and modernized instrumentation compared with the legacy 3DKnee system should also drive higher surgeon adoption rates.
Although TAVR-related stroke rates have been diminishing, it remains a devastating complication of the procedure. Two companies with devices to deflect or collect emboli are embarking on IDE trials that they hope will make cerebral embolic protection a standard of care in TAVR and perhaps other cardiac surgeries, as it already is in carotid artery stenting.